MURRAY COD AUSTRALIA LIMITED — Director's Dealing 2022

Jan 9, 2022

==> picture [82 x 105] intentionally omitted <==

Murray Cod Australia Ltd

ASX:MCA

ASX ANNOUNCEMENT

10 January 2022

Share Issues to Director on Conversion of Options and Performance Rights

Murray Cod Australia Ltd (MCA:ASX) (‘ MCA ’ or ‘ the Company ’) advises that it has today issued 30 million fully paid ordinary shares to a company associated with Director, Mr Ross Anderson upon conversion of 15 million performance rights and exercise of 15 million unlisted options at 7.5 cents each.

The performance rights were issued as partial consideration for the acquisition of the Murray Cod aquaculture assets & land as part of MCA’s relisting on the ASX in January 2017, with the terms detailed in the Replacement Prospectus dated 5 December 2016. These performance rights fully vested upon the Company producing and selling 50 to 150 tonnes of Murray Cod before the relevant milestone date. The Company’s auditor, PinnacleHPC Pty Ltd, has independently confirmed the satisfaction of the respective vesting milestones for the performance rights.

A change of Director interest notice for Mr Anderson is following.

ABOUT THE COMPANY

Murray Cod Australia is a vertically integrated producer, involved in the breeding, growing and supply of premium “Aquna” branded Murray Cod to domestic and export markets. The production process produces a unique fish with some of the best culinary qualities in the world. Murray Cod Australia uses an innovative farming technique with market-leading bio-security techniques whilst being environmentally friendly and sustainable. The Company has developed a land-based aquaculture model, using dams and irrigation water, allowing control of the breeding, feeding, water conditions and biological inputs throughout the entire lifecycle of the fish. This provides confidence for customers in the quality and sustainability of the produce. The business’ operations are located in the Riverina region of New South Wales, Australia.

For more information contact: Mr. Ross Anderson (Chairman), +61 269 625 470

The release of this announcement was authorised by the Board of Directors.

Murray Cod Australia Ltd ABN 74 928 625 Level 1, 153 Yambil Street Griffith NSW Australia 2680

Ph +61 269 625 470 www.aquna.com

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Murray Cod Australia Ltd ABN 74 143 928 625

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

We (the entity) give ASX the following the director for the purposes of section	information under listing rule 3.19A.2 and as agent for 205G of the Corporations Act.
Name of Director	Ross Anderson
Date of last notice	26 November 2021

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Anderson’s Investment Service P/L ATF ClearPoint Capital Global Markets Fund (Trustee & Beneficiary) Kimbalex Investments Pty Ltd ATF Kimbalex Trust (Trustee & Beneficiary) Citicorp Nominees Pty Ltd (beneficiary)
Date of change	10 January 2022

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held prior to change	Anderson’s Investment Service P/L ATF ClearPoint Capital Global Markets Fund - 31,566,010 fully paid ordinary shares Kimbalex Investments Pty Ltd ATF Kimbalex Trust - 15,000,000 Unlisted Options with an exercise price of $0.075 and expiring 16 January 2022 - 15,000,000 Performance Rights converting 1:1 to fully paid ordinary Shares - 1,250,000 unlisted options exercisable at $0.25 each, expiring on 3 January 2025 - 1,250,000 unlisted options exercisable at $0.25 each, expiring on 3 January 2025, vesting on 1 July 2022 - 1,250,000 unlisted options exercisable at $0.25 each, expiring on 3 January 2025, vesting on 1 July 2023 - 1,250,000 unlisted options exercisable at $0.25 each, expiring on 3 January 2025, vesting on 1 July 2024 - 1,250,000 unlisted options exercisable at $0.53 each, expiring on 25 November 2025, vesting on 1 July 2022 - 1,250,000 unlisted options exercisable at $0.53 each, expiring on 25 November 2025, vesting on 1 July 2023 - 1,250,000 unlisted options exercisable at $0.53 each, expiring on 25 November 2025, vesting on 1 July 2024 - 1,250,000 unlisted options exercisable at $0.53 each, expiring on 25 November 2025, vesting on 1 July 2025 Citicorp Nominees Pty Ltd 944,582 fully paid ordinary shares
Class	Fully paid ordinary shares
Number acquired	30,000,000
Number disposed

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation

15,000,000 fully paid ordinary shares on exercise of unlisted options at $0.075 each. 15,000,000 fully paid ordinary shares on conversion of performance rights for nil consideration.

No. of securities held after change

Anderson’s Investment Service P/L ATF ClearPoint Capital Global Markets Fund - 31,566,010 fully paid ordinary shares Kimbalex Investments Pty Ltd ATF Kimbalex Trust - 30,000,000 fully paid ordinary shares - 1,250,000 unlisted options exercisable at $0.25 each, expiring on 3 January 2025 - 1,250,000 unlisted options exercisable at $0.25 each, expiring on 3 January 2025, vesting on 1 July 2022 - 1,250,000 unlisted options exercisable at $0.25 each, expiring on 3 January 2025, vesting on 1 July 2023 - 1,250,000 unlisted options exercisable at $0.25 each, expiring on 3 January 2025, vesting on 1 July 2024 - 1,250,000 unlisted options exercisable at $0.53 each, expiring on 25 November 2025, vesting on 1 July 2022 - 1,250,000 unlisted options exercisable at $0.53 each, expiring on 25 November 2025, vesting on 1 July 2023 - 1,250,000 unlisted options exercisable at $0.53 each, expiring on 25 November 2025, vesting on 1 July 2024 - 1,250,000 unlisted options exercisable at $0.53 each, expiring on 25 November 2025, vesting on 1 July 2025 Citicorp Nominees Pty Ltd - 944,582 fully paid ordinary shares

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3

Appendix 3Y Change of Director’s Interest Notice

Nature of change Exercise of 15,000,000 unlisted options ($0.075 Example: on-market trade, off-market trade, exercise of options, exercise price, expiring 16/01/22) and conversion of issue of securities under dividend reinvestment plan, participation in 15,000,000 performance rights. buy-back

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?
If prior written clearance was provided, on what date was this provided?

• See chapter 19 for defined terms.

Appendix 3Y Page 4

01/01/2011